Therapeutic improvement of adenomyosis by supramolecular cells-based macrophage membrane-encapsulated dydrogesterone nanoparticles via targeted drug delivery and inhibition of inflammation in the uterus

Renwen Zhang, Yixing Zou, Aihua Liao, Jing Luo
In: Chinese Chemical Letters · 2025 · vol. 37(8) , pp. 111758 · doi:10.1016/j.cclet.2025.111758 · W4413810583
OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-06 ⓘ

This study developed macrophage membrane-encapsulated dydrogesterone nanoparticles for targeted delivery to the uterus, showing therapeutic improvement of adenomyosis by inhibiting inflammation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

adenomyosis

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (37)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-10-12T06:33:14.382917+00:00
License: CC0 · commercial use OK